Mesoporous Silica Microparticles Enhance the Cytotoxicity of Anticancer Platinum Drugs

被引:133
作者
Tao, Zhimin [1 ]
Toms, Bonnie [2 ]
Goodisman, Jerry [1 ]
Asefa, Tewodros [1 ]
机构
[1] Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA
[2] SUNY Syracuse, Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA
基金
日本学术振兴会; 美国国家科学基金会;
关键词
mesoporous materials; nanomaterials; adsorption capacity; endocytosis; cell viability; CONTROLLED-RELEASE; CANCER-CELLS; CELLULAR RESPIRATION; NANOPARTICLES; DELIVERY; FUNCTIONALIZATION; DOXORUBICIN; CHEMOTHERAPY; INHIBITION; MOLECULES;
D O I
10.1021/nn9015345
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We report on the endocytosis and the time-dependent enhanced cytotoxicity of anticancer platinum drugs when the drugs are combined with (or loaded into) one of the two most common types of mesoporous silica materials, MCM-41 or SBA-15. The anticancer drug cisplatin and its isomer transplatin, when loaded on MCM-41 and SBA-15 microparticles, were less cytotoxic to leukemia cells than the drugs alone after 12 h exposure. However, the drug-loaded microparticles exhibited unprecedented enhanced cytotoxicity to the cancerous cells after 24 h of exposure. This cytotoxicity of the drug-loaded microparticles was even higher than of the pure drugs in solutions, suggesting that mesoporous silica microparticles loaded with cisplatin or transplatin enabled a localized intracellular release of the platinum compounds and possibly also facilitated the drug's hydrolysis, enhancing the desired cytotoxic effect.
引用
收藏
页码:789 / 794
页数:6
相关论文
共 34 条
[1]   INTRASTRAND CROSS-LINKS ARE NOT FORMED IN THE REACTION BETWEEN TRANSPLATIN AND NATIVE DNA - RELATION WITH THE CLINICAL INEFFICIENCY OF TRANSPLATIN [J].
BOUDVILLAIN, M ;
DALBIES, R ;
AUSSOURD, C ;
LENG, M .
NUCLEIC ACIDS RESEARCH, 1995, 23 (13) :2381-2388
[2]   Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug-Resistant Cancer Cells [J].
Chen, Alex M. ;
Zhang, Min ;
Wei, Dongguang ;
Stueber, Dirk ;
Taratula, Oleh ;
Minko, Tamara ;
He, Huixin .
SMALL, 2009, 5 (23) :2673-2677
[3]  
Dabrowiak J., 2009, METALS MED
[4]   Cytotoxicity of mesoporous silica nanomaterials [J].
Di Pasqua, Anthony J. ;
Sharma, Krishna K. ;
Shi, Yan-Li ;
Toms, Bonnie B. ;
Ouellette, Wayne ;
Dabrowiak, James C. ;
Asefa, Tewodros .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2008, 102 (07) :1416-1423
[5]   Is cisplatin-induced cell death always produced by apoptosis? [J].
Gonzalez, VM ;
Fuertes, MA ;
Alonso, C ;
Perez, JM .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :657-663
[6]   The biocompatibility of mesoporous silicates [J].
Hudson, Sarah P. ;
Padera, Robert F. ;
Langer, Robert ;
Kohane, Daniel S. .
BIOMATERIALS, 2008, 29 (30) :4045-4055
[7]   Organic functionalization and morphology control of mesoporous silicas via a co-condensation synthesis method [J].
Huh, S ;
Wiench, JW ;
Yoo, JC ;
Pruski, M ;
Lin, VSY .
CHEMISTRY OF MATERIALS, 2003, 15 (22) :4247-4256
[8]   Cooperative catalysis by general acid and base bifunctionalized mesoporous silica nanospheres [J].
Huh, S ;
Chen, HT ;
Wiench, JW ;
Pruski, M ;
Lin, VSY .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (12) :1826-1830
[9]   The resurgence of platinum-based cancer chemotherapy [J].
Kelland, Lloyd .
NATURE REVIEWS CANCER, 2007, 7 (08) :573-584
[10]   ORDERED MESOPOROUS MOLECULAR-SIEVES SYNTHESIZED BY A LIQUID-CRYSTAL TEMPLATE MECHANISM [J].
KRESGE, CT ;
LEONOWICZ, ME ;
ROTH, WJ ;
VARTULI, JC ;
BECK, JS .
NATURE, 1992, 359 (6397) :710-712